Risk of chronic kidney disease increases with age and comorbidities such as hypertension, diabetes, and cardiovascular disease, highlighting the importance of early detection and targeted risk factor modification in primary and secondary prevention efforts.
November 2021
Gestational diabetes mellitus, diagnosed in the second or third trimester of pregnancy, presents challenges in managing blood glucose levels and preventing adverse maternal and fetal outcomes, underscoring the importance of early detection and targeted interventions in at-risk populations.
October 2021
Inverse association between fatty liver at baseline and type 2 diabetes remission over a 2-year follow-up period is observed, suggesting potential implications for understanding metabolic interactions and informing therapeutic interventions in diabetic patients with hepatic steatosis.
October 2021
Women with gestational diabetes mellitus have a significantly increased risk of calcification of the cardiac arteries, even after maintaining normal blood glucose levels post-pregnancy, highlighting the importance of cardiovascular risk assessment and preventive measures in this population.
October 2021
Systematic review evaluates the impact of clinical pharmacist interventions in type 2 diabetes management, highlighting their role in optimizing medication therapy and improving clinical outcomes for diabetic patients.
May 2021
A double-blind randomized controlled trial evaluates the effects of ASA, clopidogrel, and prasugrel on thrombotic markers and microRNA levels in patients with type 2 diabetes, providing insights into antiplatelet therapy efficacy and safety profiles in diabetic populations.
December 2020
An international panel of experts provides practical guidance and recommendations for managing diabetes during the COVID-19 pandemic, addressing unique challenges and considerations to optimize diabetes care and minimize associated risks in affected individuals.
November 2020
A survey of over 2,000 diabetics in the United States reveals that the majority are unaware of the increased risk of cardiovascular disease associated with diabetes. This highlights the need for improved education and awareness campaigns targeting diabetic patients.
November 2002